Incyte to Report 2008 Financial Results and 2009 Financial Guidance and Provide Update on Drug Discovery & Development Programs

Show Health and Fitness Publications

Wed, February 11, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan

[ Wed, Feb 11th 2009 ] - Market Wire

ZymoGenetics Reports Fourth Quarter and Year End 2008 Financial Results

[ Wed, Feb 11th 2009 ] - Market Wire

Zila Completes First Phase of Global Marketing In .. or Oral Cancer Screening Product, ViziLite® Plus

[ Wed, Feb 11th 2009 ] - Market Wire

Pacific Biometrics, Inc.: Pacific Biometrics to H .. r Conference Call on Wednesday, February 18, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

ImmuCell Corporation: ImmuCell Announces Financial Results for 2008

[ Wed, Feb 11th 2009 ] - Market Wire

Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. nce of Claims Relating to Heat Shock Protein dnaJ

[ Wed, Feb 11th 2009 ] - Market Wire

BioElectronics Corporation: BioElectronics Announces Major Shipments

[ Wed, Feb 11th 2009 ] - Market Wire

Lpath, Inc.: Category Leader Lpath Establishes Key 2009 Goals

[ Wed, Feb 11th 2009 ] - Market Wire

Angeion to Announce 2009 First-Quarter Results on Wednesday, February 25

[ Wed, Feb 11th 2009 ] - Market Wire

Synta Pharmaceuticals to Present at the ROTH Capi .. l Partners 21st Annual OC Growth Stock Conference

[ Wed, Feb 11th 2009 ] - Market Wire

Orthofix International and The Musculoskeletal Tr .. Accelerate Release Date for Trinity® Evolution"

[ Wed, Feb 11th 2009 ] - Market Wire

Genta Submits Randomized Study of Tesetaxel in Pa .. ric Cancer to FDA for Special Protocol Assessment

[ Wed, Feb 11th 2009 ] - Market Wire

Alnylam and Collaborators Publish New Pre-Clinica .. ivo Efficacy of Systemically Delivered RNAi Thera

[ Wed, Feb 11th 2009 ] - Market Wire

Professor John F. Thompson to Present at the Sixt .. Melanoma and Other Cutaneous Malignancies on Marc

[ Wed, Feb 11th 2009 ] - Market Wire

POZEN Announces February 25, 2009 Webcast of Fourth Quarter and Year End 2008 Results

[ Wed, Feb 11th 2009 ] - Market Wire

Salix Pharmaceuticals to Present at Roth Conference

[ Wed, Feb 11th 2009 ] - Market Wire

Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results

[ Wed, Feb 11th 2009 ] - Market Wire

Gilead pr©sente des donn©es montrant l?activit© d?amplification pharmacocin©tique du GS 9350

[ Wed, Feb 11th 2009 ] - Market Wire

Zacks Industry Outlook Highlights: Pfizer, Eli Lilly, Merck, Sanofi and Schering-Plough

[ Wed, Feb 11th 2009 ] - Market Wire

Micrus Endovascular Initiates VISSIT Trial with Pharos Vitesse Balloon Expandable Stent

Tue, February 10, 2009

[ Tue, Feb 10th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces Publication in The A .. oncerning Blood Volume in Critically Ill Surgical

[ Tue, Feb 10th 2009 ] - Market Wire

Significant Shareholder Calls upon Enzon to Immed .. tely Add Two Candidates to the Board of Directors

[ Tue, Feb 10th 2009 ] - Market Wire

Tenet Announces Definitive Agreement to Sell USC University Hospital

[ Tue, Feb 10th 2009 ] - Market Wire

NeuroMetrix, Inc. Reports Total Revenues of $7.2 Million for the Fourth Quarter of 2008

[ Tue, Feb 10th 2009 ] - Market Wire

Enzon Announces IND Acceptance for Its Survivin Antagonist

[ Tue, Feb 10th 2009 ] - Market Wire

Oculus Innovative Sciences to Present at the Roth .. l Partners 21st Annual OC Growth Stock Conference

[ Tue, Feb 10th 2009 ] - Market Wire

Cougar Biotechnology Announces Agreement with FDA .. nt for Phase III Trial of CB7630 (Abiraterone Ace

[ Tue, Feb 10th 2009 ] - Market Wire

PPD to Receive Milestone Payments for First Regul .. Dapoxetine) in Finland and Sweden for Treatment o

[ Tue, Feb 10th 2009 ] - Market Wire

Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics

[ Tue, Feb 10th 2009 ] - Market Wire

Quidel to Hold 2008 Fourth Quarter and Year-End F .. cial Results Conference Call on February 25, 2009

[ Tue, Feb 10th 2009 ] - Market Wire

Progenics Selects Subcutaneous Form of PRO 140, a .. vel HIV Antibody Therapy, for Further Development

[ Tue, Feb 10th 2009 ] - Market Wire

Synta Pharmaceuticals Announces First Patient Tre .. Elesclomol Monotherapy Solid Tumor Clinical Study

[ Tue, Feb 10th 2009 ] - Market Wire

Curis Reports Fourth Quarter and Year-End 2008 Financial Results

[ Tue, Feb 10th 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific, Inc. Receives a $200,000 Order for CatPro 5000 System

[ Tue, Feb 10th 2009 ] - Market Wire

Inspire Elects Alan F. Holmer to Board of Directors

[ Tue, Feb 10th 2009 ] - Market Wire

VIVUS Initiates Second Pivotal Phase 3 Trial of Avanafil for Treatment of Erectile Dysfunction

[ Tue, Feb 10th 2009 ] - Market Wire

Natus to Present at the Roth Capital Partners 21st Annual Growth Stock Conference

[ Tue, Feb 10th 2009 ] - Market Wire

Cubist Plans to Commence Patent Infringement Liti .. nteral Medicines, Inc. In Response To ANDA filing

[ Tue, Feb 10th 2009 ] - Market Wire

Dyax and Fovea Sign Development and Commercializa .. ion Agreement for DX-88 in Ophthalmic Indications

[ Tue, Feb 10th 2009 ] - Market Wire

Bioject Extends Supply Agreement with Ferring Pharmaceuticals, Inc.

Mon, February 9, 2009

[ Mon, Feb 09th 2009 ] - Market Wire

UnitedHealthcare, IBM, and Arizona Physicians to .. ndbreaking Patient-Centered Healthcare Initiative

[ Mon, Feb 09th 2009 ] - Market Wire

Clinical Data Announces Third Quarter Fiscal 2009 Financial Results

[ Mon, Feb 09th 2009 ] - Market Wire

Orthofix International Raises Concerns About Another Ramius Nominee for Orthofix Board

[ Mon, Feb 09th 2009 ] - Market Wire

Forbes Medi-Tech Inc.: Leading Healthy Lifestyle .. y Proven Benefits of Forbes Medi-Tech's Cholester

[ Mon, Feb 09th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Initiates .. nnaissance Surveys on Potash Resource in Ethiopia

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences? Security Holders Exer .. any as Result of Recently Announced Strategic Inv

[ Mon, Feb 09th 2009 ] - Market Wire

Genta Incorporated to Release Fourth Quarter Financial Results and Host Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

Curis Announces Collaborative Agreement between G .. nentech and National Cancer Institute on GDC-0449

[ Mon, Feb 09th 2009 ] - Market Wire

Synovis Life Technologies to Present at 21st Annu .. Capital Partners Growth Stock Conference Feb. 18

[ Mon, Feb 09th 2009 ] - Market Wire

Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer?s Disease

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences Announces Fiscal Third .. and Corporate Update Release and Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

UnitedHealth Group Awarded LEED® Green Building Certification

[ Mon, Feb 09th 2009 ] - Market Wire

Synta Pharmaceuticals Names Dr. Vojo Vukovic, Vice President, Clinical Research

[ Mon, Feb 09th 2009 ] - Market Wire

Theragenics Corporation® Announces Schedule for Fourth Quarter and Year-End 2008 Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

Compugen Appoints Dov Hershberg Chairman of the Board

[ Mon, Feb 09th 2009 ] - Market Wire

Inhibitex Completes Phase I Clinical Trials for F .. ad HCV Compounds for Advanced Preclinical Studies

[ Mon, Feb 09th 2009 ] - Market Wire

Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine

[ Mon, Feb 09th 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009

[ Mon, Feb 09th 2009 ] - Market Wire

EPIX Pharmaceuticals Provides Update on NASDAQ Listing Status

[ Mon, Feb 09th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Biogen Idec, CEMEX, Ford, Tata Motors and Carmike Cinemas

Sun, February 8, 2009

[ Sun, Feb 08th 2009 ] - Market Wire

Riassunto: Nei pazienti affetti da sclerosi multi .. malattia non manifesta attivit per due anni, seco

[ Sun, Feb 08th 2009 ] - Market Wire

MS Patients Treated with TYSABRI® Remain Free of .. s, According to Data Published in the Lancet Neur

Fri, February 6, 2009

[ Fri, Feb 06th 2009 ] - Market Wire

Celgene Corporation to Present at the 11th Annual BIO CEO Investor Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Proton Laboratories Inc.: Proton Labs to Begin Bottling Functional Water

[ Fri, Feb 06th 2009 ] - Market Wire

Geron to Present at BIO CEO & Investor Conference

[ Fri, Feb 06th 2009 ] - Market Wire

MEDNAX to Present at UBS Global Healthcare Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10

[ Fri, Feb 06th 2009 ] - Market Wire

Span-America Announces Termination of Hill-Rom Supply Contract

[ Fri, Feb 06th 2009 ] - Market Wire

CIGNA Announces Appearance at the UBS Global Healthcare Services Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Odyssey Healthcare to Broadcast Its Fourth Quarte .. ear-End 2008 Conference Call Live on the Internet

[ Fri, Feb 06th 2009 ] - Market Wire

LifePoint Hospitals to Broadcast Its Fourth Quart .. ear-End 2008 Conference Call Live on the Internet

[ Fri, Feb 06th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma to Present .. l Partners 21st Annual OC Growth Stock Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Advanced Medical Optics, Inc. Gives Notice of Ant .. nd Merger to Holders of Convertible Senior Subord

[ Fri, Feb 06th 2009 ] - Market Wire

Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2009 Financial Results

[ Fri, Feb 06th 2009 ] - Market Wire

Medtronic Completes Acquisition of Ablation Frontiers

[ Fri, Feb 06th 2009 ] - Market Wire

Ligand Enters into Screening Agreement with Trevena

[ Fri, Feb 06th 2009 ] - Market Wire

Biogen Idec Receives Shareholder Proposal

[ Fri, Feb 06th 2009 ] - Market Wire

Health Management Associates, Inc. Announces Four .. ear-End 2008 Earnings Conference Call and Webcast

[ Fri, Feb 06th 2009 ] - Market Wire

The Genome Center at Washington University Scales-Up on Illumina Sequencers

Thu, February 5, 2009

[ Thu, Feb 05th 2009 ] - Market Wire

Aetna Awarded $150,000 to Northern California Nonprofits in 2008

[ Thu, Feb 05th 2009 ] - Market Wire

FORTIS: Fortis publishes explanatory document on voting at General Meeting

[ Thu, Feb 05th 2009 ] - Market Wire

SCOR: Prestigious Redmayne report recognises SCOR .. d Protection reinsurance in the United Kingdom an

[ Thu, Feb 05th 2009 ] - Market Wire

Targacept to Report Fourth Quarter and 2008 Financial Results on February 12, 2009

[ Thu, Feb 05th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation Announces Fourth Quarter and Full Year 2008 Results

[ Thu, Feb 05th 2009 ] - Market Wire

Certified Diabetic Services, Inc. Terminates Asset Purchase Agreement

[ Thu, Feb 05th 2009 ] - Market Wire

BioSante Pharmaceuticals, Inc. To Present At BIO CEO and Investor Conference and ISSWSH Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Progen-Avexa Merger Notice of Meeting and Independent Expert Report

[ Thu, Feb 05th 2009 ] - Market Wire

GeneThera: GeneThera Offers Discounted Johne's Di .. ted by Government's Call to Eliminate 400,000 Hea

[ Thu, Feb 05th 2009 ] - Market Wire

Applied Biosystems Awards Genomic Research Grant to St. Jude Children?s Research Hospital

[ Thu, Feb 05th 2009 ] - Market Wire

StemCells, Inc. to Present at the 11th Annual BIO CEO & Investor Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Dr. Reddy?s Announces Five ANDA Approvals and Generic Product Launches in the US Market

[ Thu, Feb 05th 2009 ] - Market Wire

GTx, Inc. Announces Fourth Quarter and Year End 2008 Corporate Results Conference Call and Webcast

[ Thu, Feb 05th 2009 ] - Market Wire

BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B

[ Thu, Feb 05th 2009 ] - Market Wire

Cytori Patent Allowance Expands Celution® System .. n for Adipose Stem & Regenerative Cell Processing

[ Thu, Feb 05th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. he 2009 UBS Global Healthcare Services Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Myriad G .. , School Specialty, Exxon, Chevron and Transocean

[ Thu, Feb 05th 2009 ] - Market Wire

Illumina Presents Development Roadmap for Scaling its Genome Analyzer

[ Thu, Feb 05th 2009 ] - Market Wire

Exelixis Announces February 10 Webcast of Present .. at the 11th Annual BIO CEO & Investor Conference

Wed, February 4, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Sun Healthcare Group, Inc.: Sun Healthcare Group, .. ; Schedules Conference Call to Announce 2008 Earn

[ Wed, Feb 04th 2009 ] - Market Wire

Lpath, Inc.: Lpath to Provide Fourth Quarter 2008 Business Review and 2009 Plan

[ Wed, Feb 04th 2009 ] - Market Wire

Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference

[ Wed, Feb 04th 2009 ] - Market Wire

COPAXONE® is Approved for Treatment of Patients .. t Clinical Event Suggestive of Multiple Sclerosis

[ Wed, Feb 04th 2009 ] - Market Wire

Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares

[ Wed, Feb 04th 2009 ] - Market Wire

Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of

[ Wed, Feb 04th 2009 ] - Market Wire

Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry

[ Wed, Feb 04th 2009 ] - Market Wire

Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices

[ Wed, Feb 04th 2009 ] - Market Wire

Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,

[ Wed, Feb 04th 2009 ] - Market Wire

Conceptus® to Present at the ROTH 21st Annual OC Growth Stock Conference

[ Wed, Feb 04th 2009 ] - Market Wire

Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3

[ Wed, Feb 04th 2009 ] - Market Wire

Progenics Appoints Peter J. Crowley as Independent Board Member

[ Wed, Feb 04th 2009 ] - Market Wire

UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards

[ Wed, Feb 04th 2009 ] - Market Wire

EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening

[ Wed, Feb 04th 2009 ] - Market Wire

Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System

[ Wed, Feb 04th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf

[ Wed, Feb 04th 2009 ] - Market Wire

MEDNAX, Inc. Acquires Neonatal Practice

[ Wed, Feb 04th 2009 ] - Market Wire

Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures

Tue, February 3, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment

[ Tue, Feb 03rd 2009 ] - Market Wire

ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development

[ Tue, Feb 03rd 2009 ] - Market Wire

Affymax to Present at BIO CEO and Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses

[ Tue, Feb 03rd 2009 ] - Market Wire

PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM

[ Tue, Feb 03rd 2009 ] - Market Wire

Amarin to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Amedisys Acquires Two Home Health Agencies in Arizona

[ Tue, Feb 03rd 2009 ] - Market Wire

GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.

[ Tue, Feb 03rd 2009 ] - Market Wire

Inspire Announces Webcast of Presentation at BIO CEO Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement

[ Tue, Feb 03rd 2009 ] - Market Wire

Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19

Mon, February 2, 2009

[ Mon, Feb 02nd 2009 ] - Market Wire

Kindred Healthcare to Present at the UBS Global Healthcare Services Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

LHC Group and Ochsner Health System Complete Home Health Joint Venture

[ Mon, Feb 02nd 2009 ] - Market Wire

Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in

[ Mon, Feb 02nd 2009 ] - Market Wire

Ligand Announces Phase IIb Results With DARA

[ Mon, Feb 02nd 2009 ] - Market Wire

Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study

[ Mon, Feb 02nd 2009 ] - Market Wire

Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call

[ Mon, Feb 02nd 2009 ] - Market Wire

Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia

[ Mon, Feb 02nd 2009 ] - Market Wire

ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma

[ Mon, Feb 02nd 2009 ] - Market Wire

Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital

[ Mon, Feb 02nd 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)

[ Mon, Feb 02nd 2009 ] - Market Wire

Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®

[ Mon, Feb 02nd 2009 ] - Market Wire

Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment

[ Mon, Feb 02nd 2009 ] - Market Wire

Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S

[ Mon, Feb 02nd 2009 ] - Market Wire

LifePoint Hospitals Acquires Rockdale Medical Center

[ Mon, Feb 02nd 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in

[ Mon, Feb 02nd 2009 ] - Market Wire

ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results

Sun, February 1, 2009

[ Sun, Feb 01st 2009 ] - Market Wire

FORTIS: Fortis holding announcement

Sat, January 31, 2009

[ Sat, Jan 31st 2009 ] - Market Wire

FORTIS: Fortis holding publishes addendum to shareholder circular

[ Sat, Jan 31st 2009 ] - Market Wire

Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d

Fri, January 30, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification

[ Fri, Jan 30th 2009 ] - Market Wire

Teva Announces Approval of Generic Risperdal® Oral Solution

[ Fri, Jan 30th 2009 ] - Market Wire

ZOLL Announces Filing of Patent Infringement Suit .. Alsius Corporation and Alsius Medical Corporation

[ Fri, Jan 30th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer

[ Fri, Jan 30th 2009 ] - Market Wire

First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence

[ Fri, Jan 30th 2009 ] - Market Wire

DexCom Announces Pricing of Public Offering of Common Stock

[ Fri, Jan 30th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference

[ Fri, Jan 30th 2009 ] - Market Wire

GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry

[ Fri, Jan 30th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas

[ Fri, Jan 30th 2009 ] - Market Wire

Progen-Avexa Merger Update

[ Fri, Jan 30th 2009 ] - Market Wire

St. Jude Medical Announces 2009 Annual Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

SonoSite Introduces Powerful New Turbo Technology for S Series"

[ Fri, Jan 30th 2009 ] - Market Wire

GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame

[ Fri, Jan 30th 2009 ] - Market Wire

Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time

[ Fri, Jan 30th 2009 ] - Market Wire

REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us

[ Fri, Jan 30th 2009 ] - Market Wire

Santarus Submits New Drug Application for ZEGERID Tablet Product

Thu, January 29, 2009

[ Thu, Jan 29th 2009 ] - Market Wire

Universal Health Services, Inc. Announces Fourth .. ll Year 2008 Earnings Release and Conference Call

[ Thu, Jan 29th 2009 ] - Market Wire

Theravance, Inc.: Theravance to Report Fourth Qua .. Year 2008 Financial Results on February 12, 2009

[ Thu, Jan 29th 2009 ] - Market Wire

EXACT Sciences Regains NASDAQ Compliance

[ Thu, Jan 29th 2009 ] - Market Wire

CompCare Acquires Core Corporate Consulting Group, Inc.

[ Thu, Jan 29th 2009 ] - Market Wire

Proteonomix, Inc: Proteonomix, Inc. (PROT) Announ .. Dubrow, M.D., a Noted Plastic Surgeon and Partici

[ Thu, Jan 29th 2009 ] - Market Wire

DUSA Pharmaceuticals, Inc.: DUSA Elects Alexander Casdin to Board of Directors

[ Thu, Jan 29th 2009 ] - Market Wire

Synergetics USA, Inc. Appoints David M. Hable as President & Chief Executive Officer

[ Thu, Jan 29th 2009 ] - Market Wire

Fraunhofer USA to use iBioPharma?s Technology for Pandemic Flu Vaccine Research

[ Thu, Jan 29th 2009 ] - Market Wire

BioSphere Medical Schedules Fourth Quarter 2008 Financial Results Conference Call February 12

[ Thu, Jan 29th 2009 ] - Market Wire

Harte Gold Corp.: Harte Clarifies Affairs

[ Thu, Jan 29th 2009 ] - Market Wire

Somatic Systems, Inc.: Somatic Systems, Inc. Television Show to Air in Chicago

[ Thu, Jan 29th 2009 ] - Market Wire

Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5

[ Thu, Jan 29th 2009 ] - Market Wire

Oscient Pharmaceuticals Extends Maturity of its Privately Placed 5% Convertible Promissory Notes

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $590,000 to Non-Profits in Pennsylvania

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $125,000 to North Carolina Non-Profits

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $725,000 to Georgia Non-Profits

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $857,500 to Non-Profits in Florida

[ Thu, Jan 29th 2009 ] - Market Wire

Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria

[ Thu, Jan 29th 2009 ] - Market Wire

Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program

Incyte to Report 2008 Financial Results and 2009 Financial Guidance and Provide Update on Drug Discovery & Development Programs

_{//health-fitness.news-articles.net/content/2009/ .. date-on-drug-discovery-development-programs.html}
^{Published in Health and Fitness on Wednesday, February 4th 2009 at 14:16 GMT, Last Modified on 2009-02-04 14:17:31 by Market Wire}

WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter and year-end 2008 financial results conference call for 8:30 a.m. ET on Wednesday, February 18, 2009. The schedules for the press release and conference call are as follows:


				-- Q4 & YE 2008 Press Release:				February 18, 2009 at 7:00 a.m. ET

				-- Q4 & YE 2008 Conference Call:				February 18, 2009 at 8:30 a.m. ET

				-- Domestic Dial In Number:				877-407-8037

				-- International Dial In Number:				201-689-8037

				-- Conference ID #				312048

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 312048.

The conference call will also be webcast live on CCBN and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for oncology, inflammation and diabetes.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Tue, Feb 03rd 2009 ] - Market Wire

Cytokinetics, Inc.: Cytokinetics to Announce Four .. Quarter and Year End Results on February 10, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment

[ Tue, Feb 03rd 2009 ] - Market Wire

Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009

[ Mon, Feb 02nd 2009 ] - Market Wire

ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results

[ Wed, Jan 14th 2009 ] - Market Wire

PPD Issues 2009 Financial Guidance

[ Tue, Jan 13th 2009 ] - Market Wire

Incyte to Announce 2009 Objectives at JPMorgan He .. onference; JAK Inhibitor Program Highest Priority

[ Mon, Jan 12th 2009 ] - Market Wire

Bristol-Myers Squibb and ZymoGenetics Enter Global Collaboration on Novel Hepatitis C Compound

[ Mon, Jan 12th 2009 ] - Market Wire

Cubist Pharmaceuticals Announces Full Year 2008 Total Net Revenues of $433.6 Million

[ Mon, Jan 05th 2009 ] - Market Wire

Incyte to Present at the 27th Annual JPMorgan Healthcare Conference

[ Mon, Dec 22nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA '444 in the Treatment of COPD in the Horizon D

[ Tue, Dec 02nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA, '444 in the Horizon Asthma Development Progra

[ Wed, Nov 19th 2008 ] - Market Wire

GenVec Announces Interim Survival Data in Pivotal .. TNFerade"¢in Locally Advanced Pancreatic Cancer